CAI
Caris Life Sciences, Inc.
31.70$
+0.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q3 21 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +17.7% | -20.0% | +24.0% | +1.6% | +27.8% | -6.9% | +50.0% | +19.5% | +35.1% | -26.2% | +22.0% | – | |
| – | +9.1% | +16.7% | +14.5% | -8.5% | +3.5% | +7.8% | +6.0% | +2.4% | +3.8% | +4.0% | +12.4% | – | |
| – | -36.9% | -51.7% | +43.8% | +18.3% | +59.2% | -19.3% | +99.2% | +29.7% | +49.8% | -36.0% | +27.1% | – | |
| – | – | – | -27.9% | +11.5% | -1.9% | -14.9% | +8.6% | -13.7% | +47.3% | -83.1% | +502.1% | – | |
| – | +20.9% | +269.9% | -9.7% | -0.5% | -11.0% | +46.7% | +20.6% | -19.3% | +8.7% | +5.7% | +11.5% | – | |
| – | -64.7% | +862.6% | -124.9% | – | +2.4% | +6.7% | -16.8% | +20.0% | +15.4% | +2.7% | +12.2% | – | |
| – | +30.7% | -238.8% | – | -190.8% | – | – | – | +81.5% | +170.9% | -94.0% | +409.8% | – | |
| – | – | – | +47.2% | +0.9% | -3.9% | -3.6% | +50.3% | -29.7% | -15.9% | +12.8% | -28.0% | – | |
| – | +37.8% | -302.5% | – | – | – | – | – | – | +236.9% | -100.8% | – | – | |
| – | +98.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +34.8% | -317.0% | – | – | – | – | – | – | +236.9% | -100.6% | – | – | |
| – | +72.3% | -195.8% | – | – | – | – | – | – | +128.6% | -82.3% | -12.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.